You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
均瑤健康(605388.SH):與微康益生菌簽訂戰略合作協議書
格隆匯 12-27 14:36

格隆匯 12 月 27日丨均瑤健康(605388.SH)公佈,2020年12月26日,公司與微康益生菌(蘇州)股份有限公司(“微康益生菌”)在上海市簽訂了《戰略合作協議書》,協議書有效期三年,自簽訂之日起生效。合作內容如下:

1、益生菌研發方面

微康益生菌協助公司自主開發適合中國人腸道健康的乳雙歧桿菌J605、植物乳桿菌Y388專利菌種及應用解決方案,自主知識產權全部歸公司所有,微康益生菌全權負責該專利菌株的生產及產業化。非經公司書面許可微康益生菌不得向第三方提供包括但不限於乳雙歧桿菌J605、植物乳桿菌Y388在內的自主益生菌產品。協議雙方一致同意,將持續加強研發投入,共同推進實施上述菌種進行包括但不限於製劑、食品、飲品、乳製品等應用研究及功能性臨牀試驗評價。

協議履行期間,微康益生菌若對包括但不限於上述合作技術在內的益生菌產品進行改進和發展,公司對該等合作技術的應用享有優先權。

2、益生菌應用方面

雙方一致同意推動微康益生菌產品在公司益生菌發酵飲品、植物基乳酸菌飲品、功能性益生菌食品等產品層面的創新應用。

3、慢病健康管理方面

雙方一致同意基於雙方的專業優勢就益生菌產品在慢病健康管理領域應用開展相關合作。雙方將通過專業的慢病管理產品和方案及渠道客羣優勢,提供個性化、科學性的健康益生菌產品,實現互利共贏。

4、日常合作方面

為積極實施協議,保持雙方間的信息暢通,雙方之間應建立並保持長期、有效的溝通機制,開展定期培訓交流,推動建立聯合研究院定向開發、研製符合公司需求的益生菌相關產品。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account